These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2399887

  • 1. Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone.
    Vaitkus PT, Buxton AE, Josephson ME, Marchlinski FE.
    Am J Cardiol; 1990 Sep 15; 66(7):710-4. PubMed ID: 2399887
    [Abstract] [Full Text] [Related]

  • 2. Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias.
    Marchlinski FE, Buxton AE, Kindwall KE, Miller JM, Rosenthal ME, Gottlieb CD, Bloom RB, Josephson ME.
    Circulation; 1988 Sep 15; 78(3):583-91. PubMed ID: 3409498
    [Abstract] [Full Text] [Related]

  • 3. Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
    Zhu J, Haines DE, Lerman BB, DiMarco JP.
    Circulation; 1987 Oct 15; 76(4):802-9. PubMed ID: 3652422
    [Abstract] [Full Text] [Related]

  • 4. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN.
    Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357
    [Abstract] [Full Text] [Related]

  • 5. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP, Reid PR, Platia EV, Griffith LS.
    Am J Cardiol; 1985 Feb 01; 55(4):375-9. PubMed ID: 3969872
    [Abstract] [Full Text] [Related]

  • 6. Predicting ventricular tachycardia cycle length after procainamide by assessing cycle length-dependent changes in paced QRS duration.
    Marchlinski FE, Buxton AE, Josephson ME, Schmitt C.
    Circulation; 1989 Jan 01; 79(1):39-46. PubMed ID: 2910546
    [Abstract] [Full Text] [Related]

  • 7. Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia.
    Grimm W, Cho JG, Marchlinski FE.
    J Cardiovasc Electrophysiol; 1994 Apr 01; 5(4):313-22. PubMed ID: 8019707
    [Abstract] [Full Text] [Related]

  • 8. Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease.
    Pastor A, Almendral JM, Arenal A, Lorca MT, Delcán JL.
    Am J Cardiol; 1993 Dec 15; 72(18):1389-94. PubMed ID: 8256732
    [Abstract] [Full Text] [Related]

  • 9. Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
    Marill KA, deSouza IS, Nishijima DK, Senecal EL, Setnik GS, Stair TO, Ruskin JN, Ellinor PT.
    Acad Emerg Med; 2010 Mar 15; 17(3):297-306. PubMed ID: 20370763
    [Abstract] [Full Text] [Related]

  • 10. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
    Martínez-Rubio A, Shenasa M, Chen X, Wichter T, Breithardt G, Borggrefe M.
    Am J Cardiol; 1994 Feb 15; 73(5):357-60. PubMed ID: 7509121
    [Abstract] [Full Text] [Related]

  • 11. Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing.
    Naitoh N, Washizuka T, Takahashi K, Aizawa Y.
    Jpn Circ J; 1998 Apr 15; 62(4):267-73. PubMed ID: 9583460
    [Abstract] [Full Text] [Related]

  • 12. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia.
    Saksena S, Rothbart ST, Shah Y, Cappello G.
    Am J Cardiol; 1984 Aug 01; 54(3):347-52. PubMed ID: 6465016
    [Abstract] [Full Text] [Related]

  • 13. Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia.
    Chiamvimonvat N, Mitchell LB, Gillis AM, Wyse DG, Sheldon RS, Duff HJ.
    Am J Cardiol; 1992 Sep 01; 70(6):598-604. PubMed ID: 1324598
    [Abstract] [Full Text] [Related]

  • 14. Electrophysiologic mechanism of exercise-induced sustained ventricular tachycardia.
    Sung RJ, Shen EN, Morady F, Scheinman MM, Hess D, Botvinick EH.
    Am J Cardiol; 1983 Feb 01; 51(3):525-30. PubMed ID: 6823868
    [Abstract] [Full Text] [Related]

  • 15. Importance of modes of electrical termination of ventricular tachycardia for the selection of implantable antitachycardia devices.
    Waldecker B, Brugada P, Zehender M, Stevenson W, Den Dulk K, Wellens HJ.
    Am J Cardiol; 1986 Jan 01; 57(1):150-5. PubMed ID: 3942060
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM, Spielman SR, Webb CR, Sokoloff NM, Rae AP, Horowitz LN.
    Am J Cardiol; 1985 Aug 01; 56(4):277-84. PubMed ID: 4025166
    [Abstract] [Full Text] [Related]

  • 17. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
    Aizawa Y, Chinushi M, Naitoh N, Shibata A.
    Heart; 1996 Feb 01; 75(2):165-70. PubMed ID: 8673755
    [Abstract] [Full Text] [Related]

  • 18. Procainamide induced change of the width of the zone of entrainment and its relation to the inducibility of reentrant ventricular tachycardia.
    Aizawa Y, Tanabe Y, Naitoh N, Washizuka T, Shibata A, Josephson ME.
    Pacing Clin Electrophysiol; 1997 Nov 01; 20(11):2789-98. PubMed ID: 9392810
    [Abstract] [Full Text] [Related]

  • 19. Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
    Long B, Koyfman A.
    J Emerg Med; 2017 Apr 01; 52(4):484-492. PubMed ID: 27751700
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.